Press Release

Investment in A-Traction, Inc.

“MPI-1 Investment Limited Partnership” (“MPI”), the fund managed by MedVenture Partners, Inc., has completed its Series A investment as a lead investor totaling 69.9 Million Yen in A-Traction, Inc.

>>PDF File

During CRT15 that was held from February 21st through the 24th in Washington DC, MPI Chief Medical Officer Dr. Fumiaki Ikeno was a moderator and speaker for the Mobile Health session

During CRT15 that was held from February 21st through the 24th in Washington DC, MPI Chief Medical Officer Dr. Fumiaki Ikeno was a moderator and speaker for the Mobile Health session at the US-JAPAN FDA Town Hall Meeting (New Paradigms for Global Device Evaluation: The Harmonization By Doing (HBD) Japan-USA Synergies Symposium).

http://crtmeeting.org/index.php?id=78

 

~~~CRT 15 Japan Agenda  ~~~~

SESSION II: RESEARCH AND DEVELOPMENT OF MOBILE HEALTH CAN WE ADVANCE BOTH SIDES OF THE PACIFIC TOGETHER?

Fumiaki Ikeno, MD (Moderator)  Linda Ricci, FDA  (Moderator) 

10:50AM - Hampton

Mobile Health from Japan View

Fumiaki Ikeno, MD (Speaker) 

 

President Hajime Oshita and Chief Medical Officer Dr. Fumiaki Ikeno coordinated and delivered lectures at the “New Ecosystem For Medical Device Innovation” conference

MPI President Hajime Oshita and Chief Medical Officer Dr. Fumiaki Ikeno coordinated and delivered lectures at the “New Ecosystem For Medical Device Innovation” conference held at Tohoku University on October 3rd, 2014. The purpose of the conference was to initiate the building of an ecosystem for medical device innovation in Japan by collaborating with the Stanford Biodesign program, incubators from Silicon Valley, Japanese government authorities and medical device manufacturers.

http://www.ms.tohoku.ac.jp/upload/files/ecosystem_20141003.pdf

http://www.wsgr.com/news/Japan-SV-Collaboration/index.htm

Chief Medical Officer, Dr. Ikeno, delivered a lecture at IMDRF

Chief Medical Officer, Dr. Ikeno, delivered a lecture during the Japan-US Harmonization by Doing (HBD) session of the International Medical Device Regulators Forum held in Washington DC on September 19, 2014.

http://www.fda.gov/MedicalDevices/NewsEvents/WorkshopsConferences/ucm401433.htm#date

Investment in Biomedical Solutions, Inc.

“MPI-1 Investment Limited Partnership” (“MPI”), the fund managed by MedVenture Partners, Inc., has completed its Series A investment as a lead investor totaling 150 Million Yen in Biomedical Solutions, Inc. (“BSI”), along with funds managed by JAFCO Co., Ltd. and Mizuho Capital Co., Ltd.

>>PDF File

<< 1 2 >> 2Page of1page
 
Category
Archive
Press Release recent